Figure 1. Median percent donor chimerism after nonmyeloablative allogeneic HCT. The percentages of donor CD3+ T cells and granulocytes were measured on days 28, 56, and 84 after allografting.
Figure 1.

Median percent donor chimerism after nonmyeloablative allogeneic HCT. The percentages of donor CD3+ T cells and granulocytes were measured on days 28, 56, and 84 after allografting.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal